S-8 1 d310748ds8.htm S-8 S-8

As filed with the Securities and Exchange Commission on March 4, 2022    

Registration No. 333-            






Washington, D.C. 20549









Treace Medical Concepts, Inc.

(Exact name of registrant as specified in its charter)




Delaware   47-1052611
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification Number)


203 Fort Wade Rd., Suite 150

Ponte Vedra, Florida

(Address of Principal Executive Offices)   (Zip Code)

2021 Incentive Award Plan

2021 Employee Stock Purchase Plan

(Full Title of the Plan)

Jaime A. Frias

Chief Legal Officer and Corporate Secretary

Treace Medical Concepts, Inc.

203 Fort Wade Rd., Suite 150

Ponte Vedra, Florida, 32801

(904) 373-5940

(Name, address, including zip code, and telephone number, including area code, of agent for service)



Copies to:


Brian J. Cuneo

Phillip S. Stoup

Latham & Watkins LLP

140 Scott Drive

Menlo Park, California 94025

Telephone: (650) 328-4600

Facsimile: (650) 463-2600



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Proposed sale to take place as soon after the effective date of the

registration statement as awards under the plans are exercised and/or vest.





This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 3,250,864 shares of the Registrant’s common stock issuable under the following employee benefit plans for which the Registration Statement of the Registrant on Form S-8 (File No. 333-255541) are effective: (i) the 2021 Incentive Award Plan, as a result of the operation of an automatic annual increase provision therein, which added 2,709,054 shares of common stock, and (ii) the 2021 Employee Stock Purchase Plan, as a result of the operation of an automatic annual increase provision therein, which added 541,810 shares of common stock.


Pursuant to Instruction E of Form S-8, the contents of the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on April 27, 2021 (File No. 333-255541) is incorporated by reference herein.


Item 8. Exhibits.



          Incorporated by Reference       




   Form    Exhibit    Date Filed      Filed
  4.1    Amended and Restated Certificate of Incorporation of Treace Medical Concepts, Inc.    8-K    3.1      4/27/2021     
  4.2    Amended and Restated Bylaws of the Treace Medical Concepts, Inc.    8-K    3.2      4/27/2021     
  4.3    Form of Common Stock Certificate    S-1/A    4.2      4/19/2021     
  5.1    Opinion of Latham & Watkins LLP.             X
23.1    Consent of Latham & Watkins LLP (included in Exhibit 5.1).             X
23.2    Consent of Independent Registered Public Accounting Firm.             X
24.1    Power of Attorney (included in the signature page to this registration statement).             X
99.1#    2021 Incentive Award Plan and related form agreements    S-8    99.2      4/27/2021     
99.2#    2021 Employee Stock Purchase Plan    S-8    99.3      4/27/2021     
107    Filing Fee Table.             X



Indicates management contract or compensatory plan.


Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ponte Vedra, State of Florida, on this 4th day of March 2022.


Treace Medical Concepts, Inc.
By:   /s/ John T. Treace
  John T. Treace
  Chief Executive Officer


KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints John T. Treace and Mark L. Hair, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Registration Statement, including post-effective amendments or any abbreviated registration statement and any amendments thereto filed, with all exhibits thereto and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents, with full power of each to act alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.







/s/ John T. Treace

John T. Treace

   Chief Executive Officer and Director
(Principal Executive Officer)
  March 4, 2022

/s/ Mark L. Hair

Mark L. Hair

   Chief Financial Officer
(Principal Financial and Accounting Officer)
  March 4, 2022

/s/ James T. Treace.

James T. Treace

   Chairman of the Board of Directors   March 4, 2022

/s/ John K. Bakewell

John K. Bakewell

   Director   March 4, 2022

/s/ F. Barry Bays

F. Barry Bays

   Director   March 4, 2022

/s/ Lawrence W. Hamilton

Lawrence W. Hamilton

   Director   March 4, 2022

/s/ Betsy Hanna

Betsy Hanna

   Director   March 4, 2022

/s/ Deepti Jain

Deepti Jain

   Director   March 4, 2022

/s/ Richard W. Mott

Richard W. Mott

   Director   March 4, 2022

/s/ Thomas E. Timbie

Thomas E. Timbie

   Director   March 4, 2022

/s/ John R. Treace

John R. Treace

   Director   March 4, 2022